Published in Gastrointest Endosc on May 01, 2001
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc (2009) 1.66
Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus (2009) 1.32
Ablative therapies for Barrett's esophagus. Curr Gastroenterol Rep (2011) 0.88
A systematic review and meta-analysis of the treatment for Barrett's esophagus. Dig Dis Sci (2008) 0.85
Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus in patients with fundoplications. Surg Endosc (2007) 0.83
Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg (2006) 0.82
Barrett's oesophagus: the new endoscopic modalities have a future. Gut (2005) 0.80
Barrett's Esophagus, a Complication of GERD. Curr Treat Options Gastroenterol (2002) 0.80
Current endoscopic methods of radical therapy in early esophageal cancer. J Med Life (2015) 0.79
Diagnosis and management of Barrett's esophagus. Surg Clin North Am (2012) 0.78
Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol (2016) 0.77
Mucosal ablation of Barrett esophagus. Nat Rev Gastroenterol Hepatol (2009) 0.77
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. Gastrointest Cancer Res (2012) 0.76
Histology assessment of bipolar coagulation and argon plasma coagulation on digestive tract. World J Gastrointest Endosc (2014) 0.75
Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer. Gut (2003) 0.75
Barrett's esophagus--Who, how, how often and what to do with dysplasia? Can J Gastroenterol (2006) 0.75
Complications of endoscopic biliary sphincterotomy. N Engl J Med (1996) 11.10
Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N Engl J Med (1983) 7.50
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc (2001) 5.94
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 3.60
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med (2001) 3.28
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet (1994) 3.22
Amanita poisoning: treatment and the role of liver transplantation. Am J Med (1989) 3.20
Campylobacter fetus infection in human subjects: association with raw milk. Am J Med (1979) 2.99
The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesion and associated malabsorption. Gastroenterology (1971) 2.80
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol (1995) 2.73
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Symposium on pathology of the gastrointestinal tract-Part II. Small intestinal biopsy. Hum Pathol (1975) 2.40
Latent celiac sprue. Gastroenterology (1974) 2.36
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med (1992) 2.31
Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21
Sprue by any other name. Gastroenterology (1970) 2.21
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc (1991) 2.17
Serological evidence of Legionella species infection in acute exacerbation of COPD. Eur Respir J (2002) 2.15
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med (1999) 2.15
Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol (1987) 2.12
Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11
A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope. Gastrointest Endosc (1999) 2.09
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am J Surg Pathol (2000) 2.05
Electron microscopy of the intestine and rectum in acquired immunodeficiency syndrome. Gastroenterology (1985) 1.92
Cyanoacrylate glue in gastric variceal bleeding. Endoscopy (2002) 1.86
Primary abdominal lymphoma. Presenting manifestation of celiac sprue or complicating dermatitis herpetiformis. Am J Med (1977) 1.82
Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis (2001) 1.80
The small intestinal mucosa in dermatitis herpetiformis. II. Relationship of the small intestinal lesion to gluten. Gastroenterology (1971) 1.79
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax (1996) 1.78
Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther (2011) 1.77
Nonerosive reflux disease--current concepts and dilemmas. Am J Gastroenterol (2001) 1.75
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med (1991) 1.67
Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol (1995) 1.65
Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology (1983) 1.65
The quality of care in Barrett's esophagus: endoscopist and pathologist practices. Am J Gastroenterol (2001) 1.63
The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med (1999) 1.60
NSAID effect on sporadic colon polyps. Am J Gastroenterol (1993) 1.60
Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol (1983) 1.59
Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther (2007) 1.56
Seasonal variation in community-acquired pneumonia. Eur Respir J (1996) 1.54
Cytomegalovirus-associated gastric ulcer. Gastroenterology (1977) 1.53
Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients. Arthritis Rheum (1993) 1.52
Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel. Am J Surg Pathol (1999) 1.51
Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. The Liver Transplantation Database (LTD) Investigators. Hepatology (1991) 1.49
Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest (1996) 1.48
Flow cytometry in Barrett's esophagus. What have we learned so far? Dig Dis Sci (1991) 1.48
Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut (1999) 1.48
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation. Gastroenterology (1988) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: "for whom the bell tolls". Gastroenterology (1994) 1.42
Colon cancer screening: beyond efficacy. Gastroenterology (1994) 1.42
Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism "Z". Am J Respir Crit Care Med (1997) 1.42
Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc (1995) 1.41
Aetiology of respiratory tract infections: clinical assessment versus serological tests. Br J Gen Pract (2001) 1.40
The difference in colon polyp size before and after removal. Gastrointest Endosc (1996) 1.40
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects. Aliment Pharmacol Ther (2009) 1.39
The normal human esophageal mucosa: a histological reappraisal. Gastroenterology (1975) 1.35
Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.34
Sulfasalazine-induced exacerbation of ulcerative colitis. N Engl J Med (1982) 1.32
A fluorescent probe for conformational changes in skeletal muscle G-actin. J Biol Chem (1980) 1.32
Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med (1998) 1.30
The Paneth cell in disease. Gut (1969) 1.29
Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group. Gastrointest Endosc (1999) 1.27
Gastric dysplasia and its management. Gastroenterology (1994) 1.27
Simulated limnological effects of the Shasta Lake temperature control device. Environ Manage (2001) 1.26
Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol (2000) 1.25
Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology (1996) 1.22
Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol (1999) 1.22
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res (1990) 1.20
Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure. Am Surg (2001) 1.20
Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol (1973) 1.20
The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc (1996) 1.19
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol (2000) 1.18
The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy (2006) 1.16
Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration (1996) 1.14
Dysfunction of the continent ileostomy: clinical features and bacteriology. Gut (1983) 1.14
Peritoneal encapsulation of the small intestine. Gastroenterology (1970) 1.14
Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med (1999) 1.13
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. Gastrointest Endosc (2000) 1.12
Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci (1990) 1.12
Laser therapy of Barrett's mucosa. Gastrointest Endosc (1993) 1.11
Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis (1998) 1.11
The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther (2000) 1.10
Helicobacter pylori-associated gastric pathology. Gastroenterol Clin North Am (1993) 1.09
Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci (1993) 1.08
Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis (1995) 1.06
Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer (2001) 1.06
Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers. Gastrointest Endosc (1995) 1.06
Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (1994) 1.05
Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopic lesions. Gastroenterology (1993) 1.04